Gene News and Research

Latest Gene News and Research

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Vitro Diagnostics, Inc., dba Vitro Biopharma, announced the filing of a new United States patent application entitled “POU5-F1 Expression in Human Mesenchymal Stem Cells” and the development of new technology related to generation of human induced pluripotent stem cells (iPS).

2 Dec 2009

Development of novel virus can lead to new therapeutic strategy to combat cancer

Ohio State University cancer researchers have developed a tumor-attacking virus that both kills brain-tumor cells and blocks the growth of new tumor blood vessels.

2 Dec 2009

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

To address the emergence of the synthetic biology industry and to promote its potential, a group of individuals and companies announced the formation of the Synthetic Biology Industry Association (SynBIA) in Cambridge, Massachusetts last week.

2 Dec 2009

Researchers develop new application for improved detection of breast cancer cells

Single-walled nanotubes—cylinders of carbon about a nanometer in diameter—have been highly touted for potential applications such as ultrastrong fibers, electrical wires in molecular devices, or hydrogen storage components for fuel cells. Thanks to a new development by researchers at the National Institute of Standards and Technology (NIST) and five partners, you can add one more application to the list: detection and destruction of an aggressive form of breast cancer.

2 Dec 2009

ACMG welcomes SACGHS report on gene patenting and licensing practices

The American College of Medical Genetics (ACMG) has a long-standing position that genes are products of nature, and as such should not be patentable. ACMG has provided comments to the Secretary's Advisory Committee on Genetics Health and Society (SACGHS) about its views on an ongoing basis.

2 Dec 2009

TGF--1 suppresses the growth of cancer cells, find researchers

UT Southwestern Medical Center researchers have found that a naturally occurring protein -- transforming growth factor beta1 (TGF--1) -- which normally suppresses the growth of cancer cells, causes a rebound effect after a prolonged exposure.

2 Dec 2009

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

Memgen announced today that results from its ongoing, Leukemia & Lymphoma Society co-sponsored clinical trial in chronic lymphocytic leukemia (CLL) have been selected for an oral presentation at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

2 Dec 2009

New scientific breakthrough may allow doctors to reverse cleft palate in humans

In a study newly published in the journal Development, investigators at the USC School of Dentistry describe how to non-surgically reverse the onset of cleft palate in fetal mice - potentially one step in the journey to a better understanding of similar defects in humans.

2 Dec 2009

Study identifies genetic link between vitamin D and heart disease

Previous studies have shown a link between low vitamin D status and heart disease. Now a new study shows that patients with high blood pressure who possess a gene variant that affects an enzyme critical to normal vitamin D activation are twice as likely as those without the variant to have congestive heart failure.

2 Dec 2009

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Results of a large-scale clinical trial presented today at the annual meeting of the Radiological Society of North America (RSNA) provide the first strong evidence of the benefit of annual screening ultrasound for women with dense breasts who are at elevated risk for breast cancer. In addition, the study confirmed that MRI is highly sensitive in depicting early breast cancer.

2 Dec 2009

Sperm genes may have a detrimental effect on longevity, says new study

Researchers in Japan have found that female mice produced by using genetic material from two mothers but no father live significantly longer than mice with the normal mix of maternal and paternal genes. Their findings provide the first evidence that sperm genes may have a detrimental effect on lifespan in mammals.

1 Dec 2009

Control over male fertility and hope for low sperm count

A new research report published in the December 2009 print issue of The FASEB Journal could one day give men similar type of control over their fertility that women have had since the 1960s. That's because scientists have found how and where androgenic hormones work in the testis to control normal sperm production and male fertility. This opens a promising avenue for the development of "the pill" for men. The discovery also offers hope to those who cannot have children because of low sperm counts.

1 Dec 2009

NRR to be available exclusively on OvidSP online search and discovery platform to all Ovid customers

As part of ongoing efforts to strengthen its presence in China's healthcare information market, Ovid, a part of Wolters Kluwer Health and a global leader in electronic scientific, medical, and academic information research solutions, is pleased to announce an agreement with Neural Regeneration Research (NRR), an English-language monthly journal dedicated to presenting peer-reviewed, evidence-based scholarly research in stem cells and regeneration.

1 Dec 2009

Low-dose radiation increases breast cancer risk in high-risk women

Low-dose radiation from annual mammography screening may increase breast cancer risk in women with genetic or familial predisposition to breast cancer, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

1 Dec 2009

Neurotoxic heavy metal can slow the progression of Lou Gehrig's disease

New discoveries have been made about how an elevated level of lead, which is a neurotoxic heavy metal, can slow the progression of amyotrophic lateral sclerosis, or Lou Gehrig's disease - findings that could point the way to a new type of therapy.

1 Dec 2009

Clinical interventions may help cocaine abusers from using drugs and prevent relapse

When asked to inhibit their response to a "cocaine-cues" video, active cocaine abusers were, on average, able to suppress activity in brain regions linked to drug craving, according to a new study at the U.S. Department of Energy's Brookhaven National Laboratory. The results, to be published in an upcoming issue of NeuroImage, suggest that clinical interventions designed to strengthen these inhibitory responses could help cocaine abusers stop using drugs and avoid relapse.

30 Nov 2009

Bantam miRNA linked to the circadian clock

How does our biological system know that it is supposed to operate on a 24-hour cycle? Scientists at the Hebrew University of Jerusalem have discovered that a tiny molecule holds the clue to the mystery.

30 Nov 2009

ALS research collaboration receives philanthropic funding

Three prominent philanthropic organizations – The Angel Fund, The ALS Therapy Alliance and Project ALS -- dedicated to finding a treatment for amyotrophic lateral sclerosis (ALS) have financed a new collaboration between one of the world’s leading ALS researchers and RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi).

30 Nov 2009

Royal Philips Electronics demonstrates its portfolio of dose radiation managing products

Royal Philips Electronics today announced its response to an industry need by showing its portfolio of products designed to manage dose radiation at this year's 95th annual meeting of the Radiological Society of North America (RSNA) in Chicago.

From Philips Healthcare 30 Nov 2009

Study on placebo effect

A short time ago, Swedish scientists published a paper suggesting the existence of a genetic disposition to respond to placebo, thus giving rise to debate in the media about a possible "placebo gene." In the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[46]: 751-5), Matthias Breidert and Karl Hofbauer summarize the most recent data about placebos.

28 Nov 2009

Gene News and Research

Latest Gene News and Research

Vitro Diagnostics files a patent application for its technology related to generation of iPS cells

Development of novel virus can lead to new therapeutic strategy to combat cancer

SynBIA formed to address the emergence of synthetic biology industry and to promote its potential

Researchers develop new application for improved detection of breast cancer cells

ACMG welcomes SACGHS report on gene patenting and licensing practices

TGF--1 suppresses the growth of cancer cells, find researchers

Results from ongoing clinical trial of ISF35 to be presented at ASH annual meeting

New scientific breakthrough may allow doctors to reverse cleft palate in humans

Study identifies genetic link between vitamin D and heart disease

Annual screening ultrasound may benefit women who are at elevated risk for breast cancer

Sperm genes may have a detrimental effect on longevity, says new study

Control over male fertility and hope for low sperm count

NRR to be available exclusively on OvidSP online search and discovery platform to all Ovid customers

Low-dose radiation increases breast cancer risk in high-risk women

Neurotoxic heavy metal can slow the progression of Lou Gehrig's disease

Clinical interventions may help cocaine abusers from using drugs and prevent relapse

Bantam miRNA linked to the circadian clock

ALS research collaboration receives philanthropic funding

Royal Philips Electronics demonstrates its portfolio of dose radiation managing products

Study on placebo effect

eBook: Using iPSCs models for human disease research and drug discovery eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey